News Hella Kohlhof

(1 - 14 von 21
)

RPPApipe: Publications

www.cogsys.cs.uni-tuebingen.de
RPPApipe - A pipeline for the analysis of reverse-phase protein array data.

DGAP-News: 4SC AG: 4SC auf der ASCO: 4SC 202 und...

www.finanznachrichten.de
· Dr. Hella Kohlhof, Director of Product Development bei 4SC ...

finanzen.net - Seite nicht gefunden

www.finanzen.net
DGAP-News: Pressemitteilung: 4SC prsentiert auf ASCO finale Ergebnisse aus Phase-I-AEGIS-Studie sowie Rationale fr tgliches Dosierungsschema des Krebswirk... |...

Immunic verstärkt Management Team und Aufsichtsrat (News mit...

www.eqs-news.com
"Wir freuen uns, dass Daniel Vitt und Hella Kohlhof das Managementteam der Immunic substanziell verstärken.

BSN: EpiCongress Boston

www.biotechsciencenews.com
09:00:00, Translating Epigenetic Regulation to Clinical Oncology, Hella Kohlhof. 13:00:00, Pathway-based Application of Epigenetic Drugs to Optimize Clinical ...

IMMUNIC, INC. : Change in Directors or Principal Officers ...

www.marketscreener.com
— reference. Dr. Hella Kohlhof Agreement. Immunic AG entered into a third amendment to the Service Agreement (as amended, the ... › ...

Dentons advises Immunic on second closing of series A ...

www.dentons.com
— ... Dr. Daniel Vitt (CEO) and Dr. Hella Kohlhof (CSO) in addition to the existing members Dr.Manfred Groeppel and Dr. Andreas Muehler. › february

Immunic enters into a global option and license agreement ...

www.lspvc.com
— ... a big step in the therapy of IBD beyond the current state-of-the-art in this disease,” commented Dr. Hella Kohlhof, CSO of Immunic AG. › news › im...

Immunic presents data on IMU-856 at Crohn's and colitis ...

www.drugdiscoverynews.com
— Hella Kohlhof, the company's chief scientific officer, presented data on IMU-856 for the first time at the IBD Innovate: Product Development for ... › ...

Immunic, Inc. Announces First Psoriasis Patient Enrolled in Ongoing...

www.wfmz.com
— ... a range of cytokines involved in various immune-mediated diseases," added Hella Kohlhof, Ph.D., Chief Scientific Officer of Immunic. › News

IMU-838 Shows Strong Activity in Preclinical Models of UC, Immunic ...ibdnewstoday.com › › imu-838-shows-s...

ibdnewstoday.com
· New unpublished data was shared by Hella Kohlhof, PhD, chief scientific officer of Immunic, during an oral presentation titled, “IMU-838 in ...

Immunic AG Awarded Research Grant by German Federal Ministry ...www.lspvc.com › news › immunic-ag-awarded-rese...

www.lspvc.com
· ... lack of selectivity, often leading to a host of serious side effects," stated Hella Kohlhof, Ph.D., Chief Scientific Officer of Immunic.

Immunic, Inc. to Participate in Investor and Scientific Conferences...

apnews.com
· October : United European Gastroenterology Week (UEGW): Hella Kohlhof, Ph.D., Chief Scientific Officer of Immunic, will present a ...
+1